|
|
||||||||
Original Research Communication |
1 From the Unit Protein Metabolism, German Institute of Human Nutrition, Bergholz-Rehbrücke, Germany (GB, KJP, AE, and CCM), and the Research Unit Nutritional Physiology "Oskar Kellner" (UH, PJ, and CCM) and the Research Unit Genetics and Biometrics (GN), Research Institute for the Biology of Farm Animals, Dummerstorf, Germany.
2 Supported by a grant from the Deutsche Forschungsgemeinschaft (Bonn, Germany) and a travel grant from NATO (Brussels).
3 Reprints not available. Address correspondence to CC Metges, Research Unit Nutritional Physiology, Research Institute for the Biology of Farm Animals, Wilhelm-Stahl-Allee 2, 18196 Dummerstorf, Germany. E-mail: metges{at}fbn-dummerstorf.de.
| ABSTRACT |
|---|
|
|
|---|
Objective: We sought to explore whether the low lysine intake from a wheat glutenbased diet is balanced by enhanced microbial lysine contribution in a pig model.
Design: Twenty miniature pigs (minipigs) fitted with ileo-ileal cannulas were fed 2 wheat glutenbased diets. One diet provided 2.7 g lysine/kg diet (WG diet) and one diet was supplemented with crystalline lysine to provide 6.6 g lysine/kg diet (WG+Lys diet). Both diets were fed for 10 or 100 d (n = 5 per group): 10WG+Lys, 10WG, 100WG+Lys, and 100WG diets. Ileal microbial lysine, which we considered to be the precursor pool for absorption, was labeled by oral administration of 15NH4Cl for the final 10 d. On days 10 and 100, a 10-h fast-fed tracer protocol with [1-13C]lysine was performed.
Results: Lysine rates of appearance decreased by 25% with the WG diet in the fed state but increased by 50% with the WG+Lys diet in the fasted state (P < 0.05). Daily gross microbial lysine contribution was lower (P < 0.05) with the WG diet (205.3 µmol · kg- 1 · d-1) than with the WG+Lys diet (370.7 µmol · kg- 1 · d-1), irrespective of the adaptation period and was similar to the ileal lysine loss with the WG diet. In the WG groups, incorporation of microbial lysine increased in the duodenum and liver (P < 0.05) but not in whole-body and muscle proteins.
Conclusion: Minipigs fed the WG diet did not adapt by showing an enhanced absorption of microbial lysine to the extrasplanchnic tissues, presumably because microbial lysine continues to be used for splanchnic protein synthesis.
Key Words: Miniature pig, microbial amino acids, ileal cannula, plasma lysine kinetics, small intestine, microflora, low-lysine diet, wheat gluten, [15N]lysine, gas chromatography combustion isotope ratio mass spectrometry, GC-CIRMS
| INTRODUCTION |
|---|
|
|
|---|
Diets in developing countries are low in lysine (31 mg/g protein) because the intake of proteins is mainly from grains, particularly wheat (9 ). The habitual lysine intake in parts of the developing world is below the FAO/WHO/UNU recommendation, which is based on the protein digestibilitycorrected amino acid score (10 , 11 ). Various metabolic adaptation and accommodation processes ensure survival if the protein or indispensable amino acid intake is not severely compromised (12 ). Therefore, we hypothesized that at low dietary lysine intakes, as is the case with the consumption of a wheat glutenbased diet, the body may be supplied by an additional amount of lysine made available by intestinal microbial lysine synthesis due to an adaptational response. Generally, it is believed that physiologic adjustments to alterations in the intake of an indispensable amino acid are complete within
1 wk. Because lysine is an amino acid that is particularly well conserved in the body, we anticipated that an increased contribution of microbial lysine might only occur after long-term adaptation (13 15 ).
Hence, the objectives of our study were to 1) compare the microbial lysine contribution (MLC) to plasma lysine turnover and whole-body and intestinal proteins with a wheat glutenbased semisynthetic diet (WG diet) and the WG diet supplemented with lysine (WG+Lys) and 2) determine whether changes in whole-body and microbial lysine and nitrogen metabolism occurring within 10 d of adjustment to the WG diet are maintained over a 100-d dietary adaptation time (10 or 100 d). We used minipigs as a human model.
| MATERIALS AND METHODS |
|---|
|
|
|---|
23 kg (10-d adaptation) or 17 kg (100-d adaptation), they were randomly assigned to 4 feeding groups (see below) and then housed individually. At termination of the experiment, all animals were 6 mo old. The maintenance requirement for lysine is similar in humans and pigs, and pigs are suitable model animals for nutritional studies in humans (16 , 17 ). Furthermore, the absorption of microbial lysine due to coprophagy only, as shown in rats, could be excluded (8 ). We used minipigs as experimental subjects because tracer material can be used more economically because of the lower adult body weight of minipigs than of conventional pigs.
To simulate a diet with a low lysine intake, such as is consumed in developing countries, a diet with wheat gluten (2.7 g lysine/kg diet, protein digestibilitycorrected amino acid score 0.5, and 25 mg lysine/g protein; 11) as the only protein source was chosen (Table 1
). Because there is no specific data on the lysine requirement of adult minipigs at a body weight of 1525 kg (19 ), we assumed that the developmental stage of the minipigs is comparable with that of young adult conventional pigs with a body weight of 120150 kg body weight. Thus, the lysine content of the WG+Lys diet was chosen according to the feed tables of the German Agricultural Association (20; total lysine requirement: 268 mg lysine/kg0.75). This is equivalent to
80 mg lysine · kg- 1 · d-1. A lysine intake of 104 mg · kg- 1 · d-1 in the WG+Lys groups was adequate, whereas the WG groups received
50% of this amount (Table 1
). The lysine content of the WG+Lys diet was
6 times that of the maintenance lysine requirements of growing conventional pigs (36 mg/kg0.75; 16).
|
1 g/d. The minipigs were fed twice per day (0800 and 1500), and water was offered ad libitum. During the final 10 d of the respective experimental periods, the minipigs received 15NH4Cl orally [95 atom percent (AP); Berlin Chemie, Berlin] to label intestinal microbial lysine. At the beginning of the investigations, 2 minipigs from each group were given 28 mg 15NH4Cl · kg-1 · d-1, equivalent to 7.7 mg N · kg-1 · d-1. After we were confident that the plasma [15N]lysine enrichment was high enough to be detected, the remaining 3 minipigs from each group received 20 mg 15NH4Cl · kg-1 · d-1, corresponding to 5.5 mg N · kg-1 · d-1. This does not affect the assessment of the MLC because this variable is based on a ratio (see "Evaluation of primary data" below). Immediately before feeding began, the 15NH4Cl tracer was mixed with a small portion of food. Care was taken that the tracer was consumed entirely.
The animals were surgically prepared with an ileo-ileal re-entrant cannula 18 d before the start of oral 15NH4Cl administration (21 ). After 10 d of recovery, the minipigs were transferred to metabolic cages where they were housed individually until the end of the experiment. Three days before the 15NH4Cl administration phase, jugular vein and carotid artery catheters (customized with the use of sterile silastic tubing 602285; Aromando Medizintechnik GmbH, Düsseldorf, Germany) were placed for tracer infusions and blood sampling, respectively. Catheters were kept open by a constant infusion (0.7 mL/h) of physiologic saline containing heparin (10 000 IU/L, heparin-sodium; B Braun Melsungen AG, Melsungen, Germany) and sulfonamide (2 mL/L; Sulfadimidin as sodium salt; Serumwerk Bernburg AG, Bernburg, Germany).
Tracer-infusion studies
On day 10 (10WG+Lys and 10WG groups) and day 100 (100WG+Lys and 100WG groups) of the experimental period, a 10-h tracer protocol was conducted after an overnight fast. Tracer solutions were prepared under sterile conditions in physiologic saline. At 0800, a constant intravenous infusion of L-[1-13C]lysine · HCl (99 AP, 5 µmol · kg- 1 · h-1; MassTrace, Woburn, MA) was started after intravenous priming doses of NaH13CO3 (99 AP, 1.0 µmol/kg; CIL, Andover, MA) and [13C]lysine (7.5 µmol/kg) with the use of a screw-driven syringe pump (model 22; Harvard Apparatus, South Natick, MA). During the first 4 h of the infusion, no food was given, and then the minipigs were fed meals every half hour from 1200 to 1800. One-twelfth of the daily intake was consumed per meal; the first and last meals contained 15NH4Cl.
Sample collection and analysis
Postabsorptive blood samples were drawn from the carotid catheter into lithium heparincontaining tubes (Monovette; Sarstedt AG & Co, Nümbrecht, Germany) before (day -1) and on days 3, 5, 7, 9, and 10 of the 15NH4Cl administration period. These time points corresponded to days 89, 93, 95, 97, 99, and 100 of the experimental period in the groups adapted to the diets for 100 d (100WG+Lys and 100WG diets). On the day of the [13C]lysine infusion, baseline blood samples were obtained, and then blood was withdrawn every 30 min during the last 2 h of the fasted (120240 min) and fed (480600 min) periods, respectively. Plasma was separated by centrifugation (10 min, 4 °C, 900 x g) and stored frozen at -80 °C until analyzed.
By means of ileo-ileal cannulas, 24-h samples of ileal chyme were collected into chilled containers on days 8, 9, and 10 of the 15NH4Cl administration period; a baseline sample was collected on day 1. Immediately after being collected, the ileal chyme was divided into aliquots of 15% and 85% (by wt). The 15% sample was stored at -20 °C and then freeze-dried, whereas the 85% sample was homogenized and conserved in an equivalent volume of 10% sodium lauryl sulfate:1% formaldehyde:physiologic saline (0.1:5:5, by vol) at 2 °C until analyzed further. The minipigs were killed by intravenous injection of hexobarbital (2 g per animal, Hexobarbital-Natrium AWD; VEB Arzneimittelwerk, Dresden, Germany) on days 11 and 101. Then, the complete gastrointestinal tract was removed to avoid contamination of tissue samples with 15N-labeled digesta. Tissue samples of the duodenum, ileum, liver, and skeletal muscle (longissimus dorsi) were frozen in liquid nitrogen immediately after being rinsed with cold physiologic saline. Mucosa of the ileum and duodenum was sampled by scraping with a horn spatula and frozen immediately in liquid nitrogen. All organ and mucosa samples were kept frozen at -80 °C. Carcasses were cut into halves, one of which was stored frozen at -20 °C for analysis of whole-body protein.
The microbial fraction of the ileal chyme was isolated by differential centrifugation for 40 min at 400 x g and 4 °C to remove food particles and then for 40 min at 22 000 x g at 4 °C (22 , 23 ). The pellet was isolated by isopropanol, precipitated with 10% trichloroacetic acid, and subsequently washed with acetone and ether. Microbial and tissue proteins (trichloroacetic acid precipitates) were hydrolyzed (6 mol HCl/L, 24 h, 110 °C), and amino acids were isolated and measured for [15N]lysine enrichment as previously described (5 ).
Plasma was acidified (0.1 mol HCl/L, pH 2) and poured onto a cation exchange column (Dowex 50WX8, Na+ form, 200400 mesh; Fluka, Steinheim, Germany). Free amino acids were eluted with 4 mol NH4OH/L. The eluate was dried at 60 °C under nitrogen (24 ).
To measure [15N]lysine enrichments, plasma and protein amino acids were derivatized to form N-pivaloyl-isopropyl esters as described in detail (5 , 24 ). Briefly, amino acids were esterified with the use of acetylchloride and isopropanol. The product was dried under nitrogen and dissolved in pyridine, and pivaloylchloride was added for acetylation. 15N enrichment of amino acids was measured by gas chromatographycombustion isotope ratio mass spectrometry (Finnigan delta S; ThermoFinnigan, Bremen, Germany) as reported (5 , 24 ). An Ultra 2 column (50 m x 0.32 mm internal diameter, 0.52-µm film thickness; Hewlett-Packard, Waldbronn, Germany) with helium as carrier gas (1 mL/min) was used to separate amino acid esters (injector temperature: 280 °C; oven temperature: 70 °C held 1 min; 70220 °C, ramp 3 °C per minute; 220300 °C, ramp 10 °C per minute, held for 8 min at 300 °C). With the use of splitless mode, 0.5 µL of sample was injected with an autosampler (CTC A200S; CTC Analytics, Zwingen, Switzerland). Under these conditions, the lysine derivative eluated after 60 min. Measured ratios of 15N to 14N were derived from mass-to-charge ratio (m/z) 29 to m/z 28 ion current signals of the mass spectrometer, and the standard gas used was calibrated against the international air standard. Enrichments were converted to 15N AP (5 ). For the calculation of atom percent excess (APE), the respective 15N baseline enrichment was subtracted.
Plasma [13C]lysine enrichments were determined after conversion to N-trifluoro-acetyl-propyl esters (25 ). Free amino acids were isolated from 250-µL plasma samples by cation exchange. The dried eluate was combined with acetylchloride:isopropanol (1:4, by vol), and the mixture was heated at 110 °C for 30 min. Trifluoroacetic anhydride and dichloromethane were added, and, after heating at 60 °C for 30 min, the mixture was dried and redissolved in ethylacetate and kept at -20 °C until analyzed. The plasma free [13C]lysine enrichment was analyzed with gas chromatographymass spectrometry (GC-MS) and chemical ionization by methane (SSQ710; ThermoFinnigan, Bremen, Germany). Lysine N-trifluoro-acetyl-propyl esters were separated on a DB-5MS column (30 m x 0.25 mm internal diameter, 0.25-µm film thickness; J&W Scientific, Folsom, CA). Both unlabeled and labeled lysine were measured by single ion monitoring in the range of m/z 339 to 341 [diagnostic ion lysine (M+H+)-42]. By analyzing at m/z 340/339 and 341/339 in baseline samples before the [13C]lysine infusion, it was established that there was no interference of [15N]lysine with [13C]lysine enrichment. Samples (1 µL) were injected splitless (injector temperature: 280 °C; temperature program: 100 °C for 0.5 min and 100280 °C, ramp 30 °C per minute). The enrichment calculations were based on tracer-tracee ratios and calibration curves, derived from standard mixtures (010 moles percent excess).
The nitrogen contents in lyophilized samples of ileal chyme, the microbial fraction of ileal chyme, and tissue samples were determined with a combustion analyzer (Vario EL; Elementar Analysensysteme GmbH, Hanau, Germany).
Plasma D-lysine concentrations were determined as N(O)-pentafluoropropionyl 2-propyl esters by GC-MS (electron impact ionization; SSQ710). Briefly, to 200 µL plasma, 8 nmol trans-4-(aminomethyl)cyclohexancarboxylic acid was added as internal standard, and the sample was precipitated with sulfosalicylic acid (5% wt:vol). For derivatization, 1 mL 2-propanol in acetyl chloride (8:2, by vol) was combined with the supernatant fluid and the reaction mixture was esterified at 100 °C for 1 h. The sample was subsequently dried under nitrogen at 60 °C. Dichloromethane (200 µL) and pentafluoropropionic acid anhydride (50 µL) were added, and the mixture was heated (20 min at 100 °C). The sample was evaporated and redissolved in 250 µL dichloromethane. D- and L-Lysine were separated on a ChirasilD-Val column (25 m x 0.25 mm internal diameter, 0.08-µm film thickness; Chrompack, Middelburg, Netherlands). A 1-µL sample was injected splitless (injector temperature: 270 °C; temperature program: 6070°C, ramp 2.5 °C per minute; 7090 °C, ramp 8 °C per minute; 190 °C for 5 min; carrier gas, helium) and the diagnostic ions m/z 230 and 258 for lysine and trans-4-(aminomethyl)cyclohexancarboxylic acid derivatives, respectively, were monitored. The D-lysine concentration was calculated by internal standard calibration. We measured both plasma and microbial [15N]lysine enrichments without consideration of the enantiomeric form, because we had no indication that D-lysine contributes largely to the plasma lysine pool. That this approach was justified was confirmed by measurements in postabsorptive and postprandial plasma samples taken during the [13C]lysine infusion, which resulted in a concentration of < 1% D-lysine.
The concentrations of lysine and other amino acids in plasma and proteins were determined by ion-exchange chromatography with HPLC (System Gold; Beckman Instruments GmbH, Munich, Germany) as reported previously (26 ). The plasma urea concentration was measured at a commercial laboratory (Hygiene-Institut, Potsdam, Germany) with a coupled colorimetric ultraviolet test that used glutamate dehydrogenase (EC 1.4.1.4) (Olympus System Reagent 500; Olympic Diagnostica GmbH, Hamburg, Germany).
All chemicals used were of analytic grade and obtained from several suppliers (Fluka Chemie AG, Buchs, Switzerland; Sigma-Aldrich Chemie GmbH, Steinheim, Germany; Merck, Darmstadt, Germany).
Evaluation of primary data
With the use of a steady state model, the rate of appearance of plasma [13C]lysine (Lys Ra), ie, lysine turnover, was calculated at half-hourly intervals as follows:
![]() | (1) |
where i is the tracer infusion rate (µmol · kg-1 · 30 min-1), Ei is the 13C enrichment of the administered tracer, and Ep is the 13C enrichment (MPE) in plasma under fasted (120240 min) and fed (540600 min) conditions. Steady state conditions were defined by the absence of a significant slope.
The MLC to Lys Ra was calculated from the [15N]lysine enrichment of plasma (Ep[15N]Lys ) and the ileal microbial fraction (Em[15N]Lys) on days 10 and 100, respectively, according to the following equation:
![]() | (2) |
where values during the fasted and fed periods were determined separately with the use of the mean plasma [15N]lysine enrichment calculated during the fasting (120240 min) and fed phases (480540 min). Daily MLC was computed by assuming that the animals were in the fasted and fed states for 12 h each.
The mean total daily lysine loss (Lysloss) at the terminal ileum was averaged for the last 10 d of the experiment (days 8, 9, and 10 for the short-time adaptation and days 98, 99, and 100 for the long-term adaptation) and was derived from the amount of dried ileal chyme (AILCH, g · kg- 1 · d-1), the nitrogen content in dried ileal chyme (NILCH, g N/g AILCH), and the total lysine concentration in dried ileal chyme (LysILCH, mg/N AILCH).
![]() | (3) |
LysILCH was measured on days 10 and 100 only, assuming that there was no significant difference in lysine concentrations between days 8 and 10 or days 98 and 100.
Statistical methods
Data were analyzed with a mixed model, with 2 fixed effects (lysine concentration and adaptation period), a repeated factor time (-30 min, fasting, and fed), a random factor animal, and corresponding interactions by using the PROC MIXED procedure of SAS (SAS Systems, release 8.2; SAS Institute Inc, Cary, NC) (27 ). A two-factor fixed-effects (lysine concentration and adaptation period) and one-interaction ANOVA were performed with an SAS general linear models procedure when measurements occurred only once (eg, 24-h MLC). When significant interactions were present, post hoc tests of subclasses with a Tukey-Cramer correction (to ensure a multiple test risk of first kind
0.05) were applied. Significance was set at P = 0.05.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
|
|
Lysine concentrations in whole-body (carcass) protein did not differ significantly between groups (overall mean: 87 mg/g protein; data not shown). The same was observed for tissue samples (skeletal muscle, liver, ileum, ileal mucosa, duodenum, and duodenal mucosa) (data not shown). Lysine concentrations in total ileal chyme were not significantly different among groups on day 10 of the 15NH4Cl administration (Figure 1
). Lysine concentrations in the ileal microbial protein fraction amounted to 50% of that in the total ileal chyme (data not shown). No significant differences in lysine concentrations in the ileal microbial protein fraction were detected between groups (data not shown). On day -1 (before the start of the 15NH4Cl administration), the lysine concentration of total ileal chyme was influenced by the adaptation period (Table 5
). Long-term feeding of the experimental diets resulted in a reduction in lysine concentrations in the ileal chyme (Figure 1
, Table 5
). An adaptation effect was also significant for the ratio of glycine to lysine in liver tissue, with higher values after 100 d (Table 5
). Daily lysine losses at the terminal ileum were not significantly different among groups (Table 2
).
[15N]Lysine enrichments and microbial lysine contribution
During the 10-d period of 15NH4Cl administration, plasma free [15N]lysine enrichments increased in all groups but were not significantly different on day 10 (Figure 2
). We detected no significant differences in [15N]lysine enrichments in the ileal microbial fraction between groups on day 10 (data not shown). However, on day 8 of 15NH4Cl administration, the effect of the dietary lysine intake was significant, with higher values in the WG group (Table 4
). Ileal microbial lysine was
10 times more enriched than was plasma free lysine in the same group (Table 4
; Figure 2
). Tissue [15N]lysine enrichments are shown in Tables 4 and 5![]()
. MLC was affected only by the lysine intake, resulting in a reduced MLC with the WG diet (Tables 3 and 4![]()
).
Plasma urea concentration
Plasma urea concentrations were higher with the WG diet than with the WG+Lys diet (Table 3
). The plasma urea concentration decreased after the start of the [13C]lysine tracer infusion (LSM ± SEM: 2.56 ± 0.15 mmol/L at -30 min compared with 1.74 ± 0.15 mmol/L fasting) and increased with feeding (2.63 ± 0.15 mmol/L).
| DISCUSSION |
|---|
|
|
|---|
Plasma lysine concentrations during the fed state were affected by the dietary lysine intake. Lower plasma lysine concentrations as a response to a low-lysine diet were also found in other studies (31 34 ). Plasma urea concentrations markedly responded to dietary lysine intakes, thus reflecting increased amino acid catabolism and urea production with the WG diet, which is a consequence of the low protein quality (35 ). Previous studies showed that the lysine intake is inversely associated with plasma urea concentrations (36 , 37 ). Lys Ra decreased with meal feeding at the lower lysine intake, in contrast with the increase that occurred during the fed state when the wheat gluten diet was supplemented with lysine (Tables 2 and 3![]()
). These observations are consistent with those from human studies and suggest that flux is stimulated when meals containing a more generous amount of amino acids are consumed (31 , 38 , 39 ). The time effect observed on some indexes was caused by the additional lysine input due to either intravenous lysine infusion or meal intake (Tables 2 and 3![]()
).
It is important to know the degree of lysine limitation with the WG diet because it might have implications for the MLC and thus for the interpretation of studies aimed at determining the lysine requirement. Body weight gain in minipigs in the WG groups was not significantly different from that in the WG+Lys groups. Additional information can be derived from preliminary lysine oxidation data (not shown), which suggests that although lysine oxidation was strongly suppressed in the WG groups, lysine balance was still positive. Thus, the WG diet, as compared with the WG+Lys diet, did not seem to be severely lysine limiting in these animals.
Because it is thought that microbially derived lysine is absorbed mainly at the terminal ileum (2 , 40 ), we cannulated minipigs at the ileal site to gain access to this precursor pool. Consequently, the ratio of plasma [15N]lysine to ileal microbial [15N]lysine measures directly the contribution to the Lys Ra. However, because circulating [15N] lysine enrichment had not achieved equilibrium, our calculations are only estimates. Nevertheless, between 9% and 16% of the microbial [15N]lysine enrichment appears in the circulation, which is consistent with earlier results (2 ). Thus, the gross MLC was equivalent to 65% and 51% of dietary lysine intakes in the WG and WG+Lys groups, respectively. Microbial [15N]lysine enrichment was not significantly different between groups on days 10 and 100, but was higher in the WG than in the WG+Lys group on days 8 and 98 (Table 4
). This suggests increased microbial lysine synthesis, although it does not provide quantitative data. Assuming, for the sake of argument, that if the absolute amount of microbial lysine reaching the circulation would have been the same with both diets, the ratio of plasma [15N]lysine to ileal microbial [15N]lysine should have been higher in the WG group because of a smaller dilution in the plasma lysine pool (Table 3
). By contrast, the ratios were not affected by lysine intake, suggesting a lower absorption rate, lower synthesis, or a higher extraction of microbial lysine by the gut with the WG diet. Thus, the MLC was lower in pigs fed the WG diet (Table 4
). However, it appears that this was due more to changes in plasma lysine turnover than to decreased absorption of microbial lysine.
To further explore the fate of microbially synthesized lysine, we measured the incorporation of microbial [15N]lysine into the protein of splanchnic tissues, skeletal muscle, and whole body. [15N]Lysine enrichment in tissue protein of the duodenum and the liver was higher at the lower lysine intake (Table 4
), whereas it did not differ significantly in whole body and muscle. This indicates that at the lower lysine intake, tissues close to the site of microbial lysine synthesis may benefit more from this source. Thus, the intestinal lysine requirement for pigs could be met in part by microbial lysine. This agrees with observations in protein-restricted piglets that lysine oxidation in portal-drained viscera is virtually absent, whereas the total lysine use of the portal-drained viscera was largely unaffected by low-protein feeding (41 ). Hence, this explains why the MLC did not increase with the WG diet. Any additional lysine input derived from the microflora was used for gut protein synthesis, and, although intestinal lysine oxidation was suppressed, even enhanced amounts of microbial lysine could not reach the peripheral circulation.
Another important question was whether lysine losses at the terminal ileum were affected by the dietary lysine supply, because a lower dietary lysine input might be counterbalanced by decreased ileal lysine losses. The total mean lysine loss did not differ among groups and ranged between 18 and 22 mg · kg-1 · d-1. This is
3 times the daily lysine loss as measured in human subjects with an ileostomy (6 ). Interestingly, the ileal lysine loss measured in the present study was similar to the daily MLC in the WG group (Table 2
). This indicates that the MLC might be important in counteracting ileal lysine losses but that it is not a net source of lysine in addition to the diet, as discussed previously (2 , 6 ). It appears that there are 2 main factors that determine whether microbial lysine synthesis is nutritionally relevant. One factor is the composition of intestinal microflora and the amount of microbial lysine produced that is affected by the type of the diet, and possibly the subsequent endogenous nitrogen secretions. The second factor is the first-pass lysine metabolism, because it determines the amount of dietary and microbial lysine eventually reaching the periphery.
Lysine concentrations in ileal chyme, the ratio of glycine to lysine in liver tissue, and 15N enrichments in whole body and muscle protein responded to long-term adaptation (Table 5
, Figure 1
). It appears that when animals had been previously adapted to the diets long term, lysine concentrations in ileal chyme were lower than in animals fed the preexperimental diet with its higher lysine content immediately before the start of the experimental feeding (Figure 1
). This may indicate that the lysine supply from both diets was not optimal, a conclusion that is supported by the increased glycine-lysine ratio after the 100-d adaptation (Table 5
). That body amino acid concentrations are not constant and that they respond to differences in dietary intakes was shown previously (29, 42 ). These observations might be related to a depletion of proteins particularly rich in the deficient indispensable amino acid (3 , 42 ). [15N]Lysine enrichments in muscle and whole body were affected by the adaptation period but in the opposite direction (Table 5
). This finding appeared to be due to experimental and biological factors that we could not identify. Overall, the dietary lysine intake had more of an effect on the observed changes than did the adaptation period (Tables 25![]()
![]()
![]()
).
To summarize, we observed intestinal de novo synthesis and absorption of microbial lysine when adult minipigs were fed wheat glutenbased diets for 10 or 100 d. The daily gross MLC to plasma lysine homeostasis was lower in the WG groups than in the WG+Lys groups; the adaptation period had no effect. Splanchnic proteins benefited more from the incorporation of microbial lysine when the WG diet was fed. By contrast, microbial lysine incorporation in muscle and whole body was not affected by the dietary lysine intake. This might be explained by previous findings in piglets (41), ie, when dietary lysine intakes are low, intestinal lysine extraction is maintained at a level observed with an adequate protein (lysine) intake and, thus, increased amounts of microbial lysine cannot reach the peripheral circulation. Lysine losses at the terminal ileum were not affected by lysine intake. It is suggested that the MLC helps to counteract ileal lysine losses, which contribute to intestinal lysine requirements being met. In conclusion, it appears that adult minipigs do not adapt to a wheat glutenbased diet via enhanced absorption of microbial lysine because of concurrent changes in lysine metabolism in the portal-drained viscera.
| ACKNOWLEDGMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. Tome and C. Bos Lysine Requirement through the Human Life Cycle J. Nutr., June 1, 2007; 137(6): 1642S - 1645S. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Baker Inaugural Article: Comparative nutrition and metabolism: Explication of open questions with emphasis on protein and amino acids PNAS, December 13, 2005; 102(50): 17897 - 17902. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Metges, K. J. Petzke, G. Backes, A. Elsner, P. Junghans, M. Derno, G. Nurnberg, and U. Hennig Response to lysine in a wheat gluten diet in adult minipigs after short-and long-term dietary adaptation as assessed with an indicator amino acid oxidation and balance technique J Anim Sci, April 1, 2005; 83(4): 833 - 841. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Hennig, C. C. Metges, A. Berk, A. Tuchscherer, and M. Kwella Relative ileal amino acid flows and microbial counts in intestinal effluents of Goettingen Minipigs and Saddleback pigs are not different J Anim Sci, July 1, 2004; 82(7): 1976 - 1985. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |